BSX - Boston Scientific Corporation

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue9,823,0009,048,0008,386,0007,477,000
Cost of Revenue2,830,0002,606,0002,447,0002,176,000
Gross Profit6,993,0006,442,0005,939,0005,301,000
Operating Expenses
Research Development1,113,000997,000920,000876,000
Selling General and Administrative3,557,0003,281,0003,083,0002,847,000
Non Recurring----
Others----
Total Operating Expenses8,099,0007,449,0006,995,0006,394,000
Operating Income or Loss1,724,0001,599,0001,391,0001,083,000
Income from Continuing Operations
Total Other Income/Expenses Net-302,000-667,000-1,214,000-1,733,000
Earnings Before Interest and Taxes1,724,0001,599,0001,391,0001,083,000
Interest Expense-241,000-229,000-233,000-284,000
Income Before Tax1,422,000932,000177,000-650,000
Income Tax Expense-249,000828,000-170,000-411,000
Minority Interest----
Net Income From Continuing Ops1,671,000104,000347,000-239,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income1,671,000104,000347,000-239,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares1,671,000104,000347,000-239,000